1.
Retrospection,stratagem,and practice on innovative drug research and development of Chinese materia medica
中药创新药物研究开发的回顾、策略与实践
2.
Application of vague comprehensive evaluation model to risk investigation in Chinese materia medica innovation project;
模糊综合评价模型在中药创新药物技术风险管理中的应用
3.
Reveal the Scientific Connotation of TCM for Promoting Its Modernization and Innovative Drug Research Process
阐明中药科学内涵 推进中药现代化与创新药物研究进程
4.
Research of Chinese Pharmaceutical Enterprise Novel Drug Development Strategy;
我国制药企业创新药物研发战略研究
5.
The Research on Biopharmaceutical Innovation Mechanism of Harbin Pharmaceutical Group
哈药集团发展生物制药创新机制研究
6.
European Innovative Medicine Initiative Plan and Its Implications for the Innovation of China s Pharmaceutical Industry;
欧洲创新药物计划给我国医药创新的启示
7.
Research on Industry-University-Research Combination for Innovation of Traditional Chinese Medicine of Guangdong Province
广东省中药新药创制中的产学研结合创新研究
8.
Comparison and Innovation Studies in Business Model of Medinine Logistics in and out China;
中外医药物流商业模式的比较与创新研究
9.
The comparative study on supervision and incentive policies of Sino-US during the innovative drug R&D
中美创新药物研发监管激励政策的比较研究
10.
Research and development of new drugs,the ways of Bayer Schering Pharma
创新药物研发——拜耳先灵医药的发展方式
11.
Dilemma of Patent Protection of the Innovative Drug with Cross-Resistance
交叉抗药性药物创新性专利保护的两难选择
12.
Current situation and constructive tactics for innovation system of Chinese materia medica industry;
我国中药产业现状与中药创新体系构建策略
13.
Discussion on the Technological Innovation and the Core Competitive Power of Chinese Traditional Patent Medicine Manufactures;
浅论技术创新与中成药制药企业的核心竞争力
14.
Linkages between R&D and Service in Pharmaceutical Innovation System:Based on the Study of Two New Drugs Innovation;
医药创新系统中的“R&D-大服务”联动:基于两个一类新药创新的研究
15.
Studies on the Innovative Anti-cancer Drug 20(S)-Ginsenoside Rg3
创新抗癌药物20（S）-人参皂苷Rg3的研究
16.
Innovation on Construction of Medicinal Plant Physiology and Ecology for The Specialty of Biological Technology
药用植物生理生态学课程建设与创新
17.
Innovation a necessary step for the research and development of new drugs after China s entry into the World Trade Organization;
创新:中国“入世”后新药研制的必由之路
18.
The Flow of Knowledge Study on the Industrial Innovation of Medical and Pharmaceutical Products in China;
中国医药产业创新中知识流动的研究